ClinicalTrials.Veeva

Menu

Platelet Reactivity in Septic Shock

U

Università degli Studi di Ferrara

Status

Completed

Conditions

Thrombocytopenia
Disseminated Intravascular Coagulation
Platelet Aggregation
Septic Shock
Sepsis

Treatments

Diagnostic Test: platelet responsiveness evaluation

Study type

Observational

Funder types

Other

Identifiers

NCT03716310
Sepsisplt

Details and patient eligibility

About

Coagulation disorders and thrombocytopenia are common in patients with septic shock. Despite the clinical relevance of sepsis-induced thrombocytopenia, few studies have focused on the prediction of thrombocytopenia in this setting. The aim of this study was to evaluate whether platelets aggregometry and markers of platelets activation, such as mean platelet volume or platelet volume distribution width, could predict sepsis-induced thrombocytopenia in patients with septic shock and normal platelet count on the day of diagnosis.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of septic shock
  • platelet count >150*103/mcL.

Exclusion criteria

  • age <18 years
  • history of any hematologic disorder
  • chronic liver failure
  • previous chemotherapy
  • transfusion of platelet during the previous 4 weeks
  • renal replacement therapy before ICU admission
  • history of antiplatelet therapy during the 8 days before inclusion
  • history of heparin-induced thrombocytopenia (HIT) or other acquired or induced thrombocytopenia
  • occurrence of HIT (defined as HIT score over 3)
  • active bleeding

Trial design

30 participants in 1 patient group

septic shock patients
Description:
Inclusion criteria of the study were diagnosis of septic shock and a platelet count \>150\*103/mcL.
Treatment:
Diagnostic Test: platelet responsiveness evaluation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems